GSK Pharma Issues Corrigendum for Postal Ballot Notice on August 3, 2026
GlaxoSmithKline Pharmaceuticals Limited issued a corrigendum to its postal ballot notice dated August 3, 2026. The correction pertains to a typographical error in Mr. Akshikar's basic salary, now stated as ₹24,00,000 per month. This corrigendum was sent to members on September 1, 2026.
The announcement is a minor correction to a previous notice and does not materially affect the company's operations or financial standing.
The announcement is a correction of a typographical error and does not contain new material financial or strategic information.
GlaxoSmithKline Pharmaceuticals Limited has issued a Corrigendum to its Postal Ballot Notice dated August 3, 2026. This corrigendum, sent via email to members on September 1, 2026, addresses a typographical error in the Explanatory Statement concerning the basic salary of Mr. Akshikar.
The corrected basic salary figure is ₹24,00,000 per month, which was previously stated incorrectly as ₹24,00,0000 per month. This Corrigendum is an integral part of the original Notice and its Explanatory Statement, which was circulated to members on August 13, 2026.
The company has also uploaded the Corrigendum on its website at https://india-pharma.gsk.com/en-in/investors/shareholder-information/postal-ballot/. All other contents of the original notice remain unchanged.
A plain-language summary of a public exchange filing by GlaxoSmithKline Pharmaceuticals Limited. Read the original for the full detail.